Wordt geladen...
Nucleostemin expression in breast cancer is a marker of more aggressive phenotype and unfavorable patients’ outcome: A STROBE-compliant article
Cancer stem cells (CSCs) are postulated to play significant role in the pathogenesis, progression as well as drug resistance of breast cancer. Nucleostemin (NS) is thought to be a key molecule for stemness, and the clinical impact of NS immunoreactivity in breast cancer can indicate its actual role...
Bewaard in:
| Gepubliceerd in: | Medicine (Baltimore) |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Wolters Kluwer Health
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6831441/ https://ncbi.nlm.nih.gov/pubmed/30817632 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000014744 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|